Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,019,485
-
Share change
-
+1,452,881
-
Total reported value
-
$337,283,258
-
Put/Call ratio
-
53%
-
Price per share
-
$8.22
-
Number of holders
-
90
-
Value change
-
+$9,255,938
-
Number of buys
-
54
-
Number of sells
-
26
Institutional Holders of TRICIDA INC - COM (TCDAQ) as of Q1 2022
As of 31 Mar 2022,
TRICIDA INC - COM (TCDAQ) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,019,485 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, VR Adviser, LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., Point72 Asset Management, L.P., Lion Point Capital, LP, COMMODORE CAPITAL LP, BAKER BROS. ADVISORS LP, STONEHILL CAPITAL MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
90
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.